2001-2005

[A101] Stang A, Anastassiou G, Ahrens W, Bromen K, Bornfeld N, Jöckel KH. The
possible role of radiofrequency radiation in the development of uveal
melanoma. Epidemiology. 2001: 12(1): 7-12
[A102] Rödelsperger K, Jöckel KH, Pohlabeln H, Römer W, Woitowitz HJ. Asbestos
and man-made vitreous fibers as risk factors for diffuse malignant
mesothelioma: results from a German hospital-based case-control study. Am
J Ind Med. 2001: 39(3): 262-75
[A103] Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P,
Brennan P, Darby SC, Forastiere F, Fortes C, Gaborieau V, Gerken M,
Gonzales CA, Jöckel KH, Kreuzer M, Merletti F, Nyberg F, Pershagen G,
Pohlabeln H, Rösch F, Whitley E, Wichmann HE, Zambon P. Lung cancer
and cigarette smoking in Europe: an update of risk estimates and an
assessment of inter-country heterogeneity. Int J Cancer. 2001: 91(6): 876-87
[A104] Merzenich H, Hartwig A, Ahrens W, Beyersmann D, Schlepegrell R, Scholze
M, Timm J, Jöckel KH. Biomonitoring on carcinogenic metals and oxidative
DNA damage in a cross-sectional study. Cancer Epidemiol Biomarkers Prev.
2001. 10(5): 515-22
[A105] Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S,
Jöckel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra
C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P. The contribution of
cigarette smoking to bladder cancer in women (pooled European data).
Cancer Causes Control. 2001: 12(5): 411-7
[A106] Stang A, Stang K, Stegmaier C, Hakulinen T, Jöckel KH. Skin melanoma in
Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev.
2001: 10(5): 407-15
[A107] Stang A, Ahrens W, Bromen K, Baumgardt-Elms C, Jahn I, Stegmaier C,
Krege S, Jöckel KH. Undescended testis and the risk of testicular cancer:
importance of source and classification of exposure information. Int J
Epidemiol. 2001: 30(5): 1050-6
[A108] Hüsing J, Sauerwein W, Hideghéty K, Jöckel KH. A scheme for a doseescalation study when the event is lagged. Stat Med. 2001: 20(22): 3323-34
[A109] Hauptmann M, Pohlabeln H, Lubin JH, Jöckel KH, Ahrens W, BrüskeHohlfeld I, Wichmann HE. The exposure-time-response relationship between
occupational asbestos exposure and lung cancer in two German case-control
studies. Am J Ind Med. 2002: 41(2): 89-97
[A109a] Jöckel KH, Bromen K, Schmidt B, Rosenbrock R. [Anti-smoking campaigns
and their contribution to health promotion]. Dtsch Med Wochenschr. 2002:
127(6): 250-1
[A110] Jöckel KH, Pohlabeln H, Bromen K, Ahrens W, Jahn I. Pet birds and risk of
lung cancer in North-Western Germany. Lung Cancer. 2002: 37(1): 29-34
1
[A111] Pohlabeln H, Wild P, Schill W, Ahrens W, Jahn I, Bolm-Audorff U, Jöckel KH.
Asbestos fibreyears and lung cancer: a two phase case-control study with
expert exposure assessment. Occup Environ Med. 2002: 59(6): 410-4
[A112] Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H,
Mann K, Siffert W, Lauterbach K, Siegrist J, Jöckel KH, Erbel R. Assessment
of clinically silent atherosclerotic disease and established and novel risk
factors for predicting myocardial infarction and cardiac death in healthy
middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL
Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart
J. 2002: 144(2): 212-8
[A113] Bender R, Jöckel KH, Richter B, Spraul M, Berger M. Body weight, blood
pressure, and mortality in a cohort of obese patients. Am J Epidemiol. 2002:
156(3): 239-45
[A114] Monárrez-Espino J, Stang A, Bromen K, Merzenich H, Anastassiou G, Jöckel
KH. Occupation as a risk factor for uveal melanoma in Germany. Scand J
Work Environ Health. 2002: 28(4): 270-7
[A115] Bromen K, Jöckel KH. Epidemiologie des Bronchialkarzinoms. Atemwegsund Lungenkrankheiten 2002: 28(11): 524-33
[A116] Baumgardt-Elms C, Ahrens W, Bromen K, Boikat U, Stang A, Jahn I,
Stegmaier C, Jöckel KH. Testicular cancer and electromagnetic fields (EMF)
in the workplace: results of a population-based case-control study in
Germany. Cancer Causes Control. 2002: 13(10): 895-902
[A117] Stang A, Jöckel KH, Baumgardt-Elms C, Ahrens W. Firefighting and risk of
testicular cancer: results from a German population-based case-control study.
Am J Ind Med. 2003: 43(3): 291-4
[A118] Rabe E, Pannier-Fischer F, Bromen K, Schuldt K, Stang A, Poncar C,
Wittenhorst M, Bock E, Weber S, Jöckel KH. Bonner Venenstudie der
Deutschen Gesellschaft für Phlebologie – Epidemiologische Untersuchung
zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten
in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003: 32: 114
[A119] Möhlenkamp S, Lehmann N, Schmermund A, Pump H, Moebus S, Baumgart
D, Seibel R, Grönemeyer DH, Jöckel KH, Erbel R. Prognostic value of
extensive coronary calcium quantities in symptomatic males--a 5-year followup study. Eur Heart J. 2003: 24(9): 845-54
[A120] Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH,
Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR,
Zeschnigk M. Tumor classification based on gene expression profiling shows
that uveal melanomas with and without monosomy 3 represent two distinct
entities. Cancer Res. 2003: 63(10): 2578-84
[A121] Stang A, Ahrens W, Baumgardt-Elms C, Stegmaier C, Bornfeld N, SchmidtPokrzywniak A, Jöckel KH. Cooking and uveal melanoma risk: results from
2
two German case-control studies. Cancer Causes Control. 2003: 14(4): 37780
[A122] Stang A, Stabenow R, Eisinger B, Jöckel KH. Site- and gender-specific time
trend analyses of the incidence of skin melanomas in the former German
Democratic Republic (GDR) including 19351 cases. Eur J Cancer. 2003:
39(11): 1610-8
[A123] Stang A, Jöckel KH. Changing patterns of skin melanoma mortality in West
Germany from 1968 through 1999. Ann Epidemiol. 2003: 13(6): 436-42
[A124] Hauner H, Meier M, Jöckel KH, Frey UH, Siffert W. Prediction of successful
weight reduction under sibutramine therapy through genotyping of the Gprotein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics.
2003: 13(8): 453-9
[A125] Stang A, Stegmaier C, Jöckel KH. Nonmelanoma skin cancer in the Federal
State of Saarland, Germany, 1995-1999. Br J Cancer. 2003: 89(7): 1205-8
[A126] Stang A, Jöckel KH. Visual disturbances in a population-based survey of
6962 subjects: the German National Health Examination Survey 1998. Eur J
Public Health. 2003: 13(3): 202-9
[A127] Jöckel KH. Re: Mesothelioma is a killer of urban men in Sweden by Kari
Hemminki and Xinjun Li. Int J Cancer. 2003: 107(4): 685
[A128] Hüsing J, Gana Dresen I, Jöckel KH. Quest for a sensible null distribution in
longitudinal microarray experiments. Computational Statistics & Data Analysis
2003: 44: 339-47
[A129] Stang A, Ahrens W, Anastassiou G, Jöckel KH. Phenotypical characteristics,
lifestyle, social class and uveal melanoma. Ophthalmic Epidemiol. 2003:
10(5): 293-302
[A130] Hüsing J, Zeschnigk M, Boes T, Jöckel KH. Combining DNA expression with
positional information to detect functional silencing of chromosomal regions.
Bioinformatics. 2003: 19(18): 2335-42
[A131] Kogevinas M, 't Mannetje A, Cordier S, Ranft U, González CA, Vineis P,
Chang-Claude J, Lynge E, Wahrendorf J, Tzonou A, Jöckel KH, Serra C,
Porru S, Hours M, Greiser E, Boffetta P. Occupation and bladder cancer
among men in Western Europe. Cancer Causes Control. 2003: 14(10): 90714
[A132] Dresen IM, Hüsing J, Kruse E, Boes T, Jöckel KH. Software packages for
quantitative microarray-based gene expression analysis. Curr Pharm
Biotechnol. 2003: 4(6): 417-37
[A133] Stang A, Jöckel KH. Studies with low response proportions may be less
biased than studies with high response proportions. Am J Epidemiol. 2004:
159(2): 204-10
[A134] Brennan P, Buffler PA, Reynolds P, Wu AH, Wichmann HE, Agudo A,
Pershagen G, Jöckel KH, Benhamou S, Greenberg RS, Merletti F, Winck C,
3
Fontham ET, Kreuzer M, Darby SC, Forastiere F, Simonato L, Boffetta P.
Secondhand smoke exposure in adulthood and risk of lung cancer among
never smokers: a pooled analysis of two large studies. Int J Cancer. 2004:
109(1): 125-31
[A135] Stang A, Jöckel KH. Trends in the incidence of ocular melanoma in the
United States, 1974-1998. Cancer Causes Control. 2004: 15(1): 95-6; author
reply 101-2
[A136] Stang A, Jöckel KH. Declining mortality rates for nonmelanoma skin cancers
in West Germany, 1968-99. Br J Dermatol. 2004: 150(3): 517-22
[A137] Stang A, Jöckel KH. Response to letter by Bray and deVries; The balance
between statistical complexity and communicability of epidemiologic study
results. Ann Epidemiol. 2004: 14(4): 306-8
[A138] Bromen K, Pannier-Fischer F, Stang A, Rabe E, Bock E, Jöckel KH. Lassen
sich geschlechtsspezifische Unterschiede bei Venenerkrankungen durch
Schwangerschaften und Hormoneinnahme erklären? [Should sex specific
differences in venous diseases be explained by pregnancies and hormone
intake?]. Gesundheitswesen. 2004: 66(3): 170-4
[A139] Stang A, Stegmaier C, Jöckel KH. Visual inspection of age-specific incidence
rates: don't forget the scaling! Arch Dermatol. 2004: 140(3): 361-2; author
reply 363
[A140] Ose C, Weiland D, Jöckel KH. Low budget GCP – am Beispiel Monitoring;
How to practice low cost monitoring in clinical trials. Informatik, Biometrie und
Epidemiologie in Medizin und Biologie 2004: 1
[A141] Stang A, Jöckel KH. Appending epidemiological studies to conventional
case-control studies (hybride case-control studies). Eur J Epidemiol. 2004:
19(6): 527-32
[A142] Hoffmann B, Moebus S, Michalsen A, Paul A, Spahn G, Dobos GJ, Jöckel
KH. Gesundheitsbezogene Kontrollüberzeugung und Lebensqualität bei
chronisch Kranken nach stationärer Behandlung mit Integrativer Medizin –
eine Beobachtungsstudie. [Health-related control belief and quality of life in
chronically ill patients after a behavioral intervention in an integrative
medicine clinic--an observational study]. Forsch Komplementarmed Klass
Naturheilkd. 2004: 11(3): 159-70
[A143] Bromen K, Stang A, Baumgardt-Elms C, Stegmaier C, Ahrens W, Metz KA,
Jöckel KH. Testicular, other genital, and breast cancers in first-degree
relatives of testicular cancer patients and controls. Cancer Epidemiol
Biomarkers Prev. 2004: 13(8): 1316-24
[A144] Schmidt-Pokrzywniak A, Jöckel KH, Bornfeld N, Stang A. Case-control study
on uveal melanoma (RIFA): rational and design. BMC Ophthalmol. 2004: 4:11
[A145] Crispo A, Brennan P, Jöckel KH, Schaffrath-Rosario A, Wichmann HE,
Nyberg F, Simonato L, Merletti F, Forastiere F, Boffetta P, Darby S. The
4
cumulative risk of lung cancer among current, ex- and never-smokers in
European men. Br J Cancer. 2004: 91(7): 1280-6
[A146] Schröder M, Hüsing J, Jöckel KH. An implementation of automated individual
matching for observational studies. Methods Inf Med. 2004: 43(5): 516-20
[A147] Stang A, Streller B, Eisinger B, Jöckel KH. Population-based incidence rates
of malignant melanoma of the vulva in Germany. Gynecol Oncol. 2005: 96(1):
216-21
[A148] Jöckel KH, Stang A. Issues in reporting epidemiological studies: study raises
several concerns. BMJ. 2005: 330(7483): 146; author reply 146-7
[A149] Stang A, Parkin DM, Ferlay J, Jöckel KH. International uveal melanoma
incidence trends in view of a decreasing proportion of morphological
verification. Int J Cancer. 2005: 114(1): 114-23
[A150] Stang A, Hense HW, Jöckel KH, Turner EH, Tramèr MR. Is it always
unethical to use a placebo in a clinical trial? PLoS Med. 2005: 2(3): e72
[A151] Stang A, Jöckel KH. Letters to the editor. The authors reply. Re: Studies with
low response proportions may be less biased than studies with high response
proportions. Am J Epidemiol 2005: 161: 402-3
[A152] Neuhäuser M, Boes T, Jöckel KH. Two-part permutation tests for DNA
methylation and microarray data. BMC Bioinformatics. 2005: 6:35
[A153] Schüler A, Weber S, Neuhäuser M, Jurklies C, Lehnert T, Heimann H,
Rudolph G, Jöckel KH, Bornfeld N, Lohmann DR. Age at diagnosis of
isolated unilateral retinoblastoma does not distinguish patients with and
without a constitutional RB1 gene mutation but is influenced by a parent-oforigin effect. Eur J Cancer. 2005: 41(5): 735-40
[A154] Stang A, Ahrens W, Baumgardt-Elms C, Bromen K, Stegmaier C, Jöckel KH.
Carpenters, cabinetmakers, and risk of testicular germ cell cancer. J Occup
Environ Med. 2005: 47(3): 299-305
[A155] Stang A, Schmidt-Pokrzywniak A, Jöckel KH. Mobile phone use and acoustic
neuromas. Epidemiology. 2005: 16(3): 414-5; author reply 417-8
[A156] Frey UH, Eisenhardt A, Lümmen G, Rübben H, Jöckel KH, Schmid KW,
Siffert W. The T393C polymorphism of the G alpha s gene (GNAS1) is a
novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers
Prev. 2005: 14(4): 871-7
[A157] Hilgers RD, Feldmann U, Jöckel KH, Klar R, Rienhoff O, Schäfer H,
Selbmann HK, Wichmann HE. Empfehlungen zur Umsetzung der
Approbationsordnung für Ärzte vom 27.06.2002 in den Fächern
Epidemiologie, Medizinische Biometrie und Medizinische Informatik. GMS
2005: 1(1): 3-14
[A158] Baumgardt-Elms C, Schümann M, Ahrens W, Bromen K, Stang A, Jahn I,
Stegmaier C, Jöckel KH. Residential exposure to overhead high-voltage lines
and the risk of testicular cancer: results of a population-based case-control
5
study in Hamburg (Germany). Int Arch Occup Environ Health. 2005: 78(1):
20-6
[A159] Xing S, Khanavkar B, Nakhosteen JA, Atay Z, Jöckel KH, Marek W;
RIDTELC Lung Study Group. Predictive value of image cytometry for
diagnosis of lung cancer in heavy smokers. Eur Respir J. 2005: 25(6): 956-63
[A160] Lutz JM, Cree I, Sabroe S, Kvist TK, Clausen LB, Afonso N, Ahrens W,
Ballard TJ, Bell J, Cyr D, Eriksson M, Févotte J, Guénel P, Hardell L, Jöckel
KH, Miranda A, Merletti F, Morales-Suarez-Varela MM, Stengrevics A, Lynge
E. Occupational risks for uveal melanoma results from a case-control study in
nine European countries. Cancer Causes Control. 2005: 16(4): 437-47
[A161] Benemann J, Lehmann N, Bromen K, Marr A, Seiwert M, Schulz C, Jöckel
KH. Assessing contamination paths of the German adult population with gold
and platinum. The German Environmental Survey 1998 (GerES III). Int J Hyg
Environ Health. 2005: 208(6): 499-508
[A162] Stang A, Moebus S, Dragano N, Beck EM, Möhlenkamp S, Schmermund A,
Siegrist J, Erbel R, Jöckel KH; Heinz Nixdorf Recall Study Investigation
Group. Baseline recruitment and analyses of nonresponse of the Heinz
Nixdorf Recall Study: identifiability of phone numbers as the major
determinant of response. Eur J Epidemiol. 2005: 20(6): 489-96
[A163] Eisenhardt A, Siffert W, Rosskopf D, Musch M, Mosters M, Roggenbuck U,
Jöckel KH, Rübben H, Lümmen G. Association study of the G-protein beta3
subunit C825T polymorphism with disease progression in patients with
bladder cancer. World J Urol. 2005: 23(4): 279-86
[A164] Bammann K, Pohlabeln H, Pigeot I, Jöckel KH. Use of an artificial neural
network in exploring the dose-response relationship between cigarette
smoking and lung cancer risk in males. Far East J. Theo. Stat. 2005: 16(2):
285-302
[A165] Brockmeyer NH, Potthoff A, Kasper A, Nabring C, Jöckel KH, Siffert W.
GNB3 C825T polymorphism and response to anti-retroviral combination
therapy in HIV-1-infected patients--a pilot study. Eur J Med Res. 2005:
10(11): 489-94
[A166] Häusler T, Stang A, Anastassiou G, Jöckel KH, Mrzyk S, Horsthemke B,
Lohmann DR, Zeschnigk M. Loss of heterozygosity of 1p in uveal melanomas
with monosomy 3. Int J Cancer. 2005: 116(6): 909-13
[A167] Stang A, Hense HW, Jöckel KH. Epidemiologie, medizinische Biometrie und
medizinische Informatik (Q1) -. Klinische Relevanz des Lehrstoffs näher
bringen – aber wie? gms Med Inform Biom Epidemiol. 2005: 1(3): Doc19
[A168] Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG,
Jöckel KH, Siffert W, Schmid KW. GNAS1 T393C polymorphism and survival
in patients with sporadic colorectal cancer. Clin Cancer Res. 2005: 11(14):
5071-7
6